Patents by Inventor Philip Livingston

Philip Livingston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glycopeptide conjugates and uses thereof
    Publication number: 20050222398
    Abstract: The present invention provides novel ?-O-linked glycoconjugates such as ?-O-linked glycopeptides, as well convergent methods for synthesis thereof. The general preparative approach is exemplified by the synthesis of the mucin motif commonly found on epithelial tumor cell surfaces. The present invention further provides compositions and methods of treating cancer using the ?-O-linked glycoconjugates.
    Type: Application
    Filed: July 23, 2004
    Publication date: October 6, 2005
    Inventors: Samuel Danishefsky, Dalibor Sames, Samuel Hintermann, Peter Glunz, Govindaswami Ragupathi, Philip Livingston, Kenneth Lloyd, Valery Kudryashov
  • Methods and compositions for heat shock protein mediated immunotherapy of melanoma
    Publication number: 20040101532
    Abstract: The present invention relates to immunotherapeutic compositions comprising an effective amount of a molecular chaperone such as a heat shock protein, preferably hsp70, non-covalently bound to one or more javelinized melanoma antigens and to methods of using the immunotherapeutic compositions to induce an immune response against melanoma in a subject. The immunotherapeutic composition may contain one or more heat shock proteins, such as one or more of hsp70, hsp90, gp96, BiP, and hsp40, and may contain one or more javelinized melanoma antigens.
    Type: Application
    Filed: January 2, 2004
    Publication date: May 27, 2004
    Inventors: Alan Houghton, Philip Livingston, Qais Al-Awqati, Mark Mayhew, Mee Hoe
  • Colon cancer KH-1 and N3 antigens
    Publication number: 20020006900
    Abstract: The present invention provides processes for the preparation of the KH-1 and N3 antigens, as well as related analgoues thereof, which are useful as anticancer therapeutics. The present invention also provides various intermediates useful in the preparation of KH-1 and N3 and analogues thereof. Additionally, the invention provides various compositions comprising any of the analogues of KH-1 and N3 available through the methods of the invention and pharmaceutical carriers useful in the treatment of subjects suffering from various forms of epithelial cancer.
    Type: Application
    Filed: April 12, 2001
    Publication date: January 17, 2002
    Inventors: Samuel J. Danishefsky, Prashant P. Deshpande, In Jong Kim, Philip Livingston, Hyun Jin Kim, Govindaswami Ragupathi, Tae Kyo Park
  • Colon cancer KH-1 and N3 antigens
    Patent number: 6238668
    Abstract: The present invention provides processes for the preparation of the KH-1 and N3 antigens, as well as related analgoues thereof, which are useful as anticancer therapeutics. The present invention also provides various intermediates useful in the preparation of KH-1 and N3 and analogues thereof. Additionally, the invention provides various compositions comprising any of the analogues of KH-1 and N3 available through the methods of the invention and pharmaceutical carriers useful in the treatment of subjects suffering from various forms of epithelial cancer.
    Type: Grant
    Filed: January 13, 1998
    Date of Patent: May 29, 2001
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Samuel J. Danishefsky, Prashant P. Deshpande, In Jong Kim, Philip Livingston, Hyun Jin Kim, Ragupathi Govindaswami, Tae Kyo Park